nodes	percent_of_prediction	percent_of_DWPC	metapath
Anisotropine Methylbromide—CHRM3—muscle of abdomen—obesity	0.011	0.591	CbGeAlD
Anisotropine Methylbromide—CHRM2—cardiovascular system—obesity	0.00147	0.0791	CbGeAlD
Anisotropine Methylbromide—CHRM1—cardiovascular system—obesity	0.00134	0.072	CbGeAlD
Anisotropine Methylbromide—CHRM3—adipose tissue—obesity	0.00106	0.0568	CbGeAlD
Anisotropine Methylbromide—CHRM2—endocrine gland—obesity	0.00101	0.0543	CbGeAlD
Anisotropine Methylbromide—CHRM3—digestive system—obesity	0.000994	0.0535	CbGeAlD
Anisotropine Methylbromide—CHRM1—endocrine gland—obesity	0.000917	0.0494	CbGeAlD
Anisotropine Methylbromide—CHRM3—endocrine gland—obesity	0.000821	0.0442	CbGeAlD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CNR1—obesity	0.000131	0.000133	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—GNB3—obesity	0.00013	0.000133	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PPARGC1A—obesity	0.00013	0.000133	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—HMOX1—obesity	0.00013	0.000132	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CNR1—obesity	0.00013	0.000132	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—TCF7L2—obesity	0.000129	0.000131	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—TCF7L2—obesity	0.000129	0.000131	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—AKT2—obesity	0.000128	0.000131	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—DRD2—obesity	0.000128	0.000131	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—AKT2—obesity	0.000128	0.00013	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—DRD2—obesity	0.000128	0.00013	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—PIK3CG—obesity	0.000127	0.00013	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—TCF7L2—obesity	0.000127	0.00013	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—PIK3CG—obesity	0.000127	0.000129	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—GNAS—obesity	0.000127	0.000129	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—GCG—obesity	0.000127	0.000129	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PTPN1—obesity	0.000127	0.000129	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—AKT2—obesity	0.000127	0.000129	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—DRD2—obesity	0.000126	0.000129	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PTPN1—obesity	0.000126	0.000129	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—GCG—obesity	0.000126	0.000129	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—PIK3CG—obesity	0.000126	0.000128	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—GCG—obesity	0.000125	0.000128	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PTPN1—obesity	0.000125	0.000128	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—APOB—obesity	0.000124	0.000127	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—PIK3CD—obesity	0.000123	0.000126	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—PIK3CD—obesity	0.000123	0.000125	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—PIK3CD—obesity	0.000122	0.000124	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—POMC—obesity	0.000121	0.000124	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PRL—obesity	0.000121	0.000123	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—POMC—obesity	0.000121	0.000123	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PRL—obesity	0.000121	0.000123	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—POMC—obesity	0.00012	0.000122	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PRL—obesity	0.000119	0.000122	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—STK11—obesity	0.000119	0.000122	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—STK11—obesity	0.000119	0.000121	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—CCL2—obesity	0.000119	0.000121	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—LPL—obesity	0.000119	0.000121	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—CCL2—obesity	0.000118	0.000121	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PLG—obesity	0.000118	0.00012	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—RHOA—obesity	0.000118	0.00012	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—STK11—obesity	0.000118	0.00012	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PLG—obesity	0.000118	0.00012	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—RHOA—obesity	0.000117	0.00012	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—CCL2—obesity	0.000117	0.000119	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—AKT2—obesity	0.000117	0.000119	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—PIK3R1—obesity	0.000117	0.000119	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PLG—obesity	0.000116	0.000119	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—AKT2—obesity	0.000116	0.000118	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—RHOA—obesity	0.000116	0.000118	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—PIK3R1—obesity	0.000116	0.000118	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—GPX1—obesity	0.000116	0.000118	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—AKT2—obesity	0.000115	0.000117	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—FOXO3—obesity	0.000115	0.000117	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—PIK3R1—obesity	0.000115	0.000117	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—ADRB2—obesity	0.000115	0.000117	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—FOXO3—obesity	0.000115	0.000117	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—ADRB2—obesity	0.000114	0.000117	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—FOXO3—obesity	0.000114	0.000116	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—ADRB2—obesity	0.000113	0.000115	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—SOCS1—obesity	0.000113	0.000115	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—CD36—obesity	0.000113	0.000115	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—SOCS1—obesity	0.000113	0.000115	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—PIK3CD—obesity	0.000112	0.000114	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—PIK3CD—obesity	0.000112	0.000114	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—SOCS3—obesity	0.000112	0.000114	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—SOCS1—obesity	0.000112	0.000114	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—SOCS3—obesity	0.000111	0.000113	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—PIK3CD—obesity	0.000111	0.000113	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—SOCS3—obesity	0.00011	0.000112	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—GNB3—obesity	0.000109	0.000111	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—GNB3—obesity	0.000109	0.000111	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—GNB3—obesity	0.000108	0.00011	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—TYK2—obesity	0.000108	0.00011	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—PIK3CB—obesity	0.000108	0.00011	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—TYK2—obesity	0.000107	0.000109	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—IGF2—obesity	0.000107	0.000109	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—PIK3CB—obesity	0.000107	0.000109	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—IGF2—obesity	0.000107	0.000109	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—RHOA—obesity	0.000107	0.000109	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—MTHFR—obesity	0.000107	0.000109	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—RHOA—obesity	0.000107	0.000109	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—GNAS—obesity	0.000106	0.000108	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—TYK2—obesity	0.000106	0.000108	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—PIK3CB—obesity	0.000106	0.000108	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—GNAS—obesity	0.000106	0.000108	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—IGF2—obesity	0.000106	0.000108	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—PIK3R1—obesity	0.000106	0.000108	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—RHOA—obesity	0.000106	0.000108	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—PIK3R1—obesity	0.000105	0.000107	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—GNAS—obesity	0.000105	0.000107	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PPARA—obesity	0.000105	0.000107	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—PIK3R1—obesity	0.000104	0.000106	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—APOB—obesity	0.000104	0.000106	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—APOB—obesity	0.000104	0.000106	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—APOB—obesity	0.000103	0.000105	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CCL5—obesity	0.000102	0.000104	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—AGT—obesity	0.000102	0.000103	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CCL5—obesity	0.000101	0.000103	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CCL5—obesity	0.0001	0.000102	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—LPL—obesity	9.95e-05	0.000101	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—APOE—obesity	9.95e-05	0.000101	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—LPL—obesity	9.92e-05	0.000101	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—FOXO1—obesity	9.88e-05	0.000101	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—RPS6KB1—obesity	9.86e-05	0.000101	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—CAV1—obesity	9.85e-05	0.0001	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—FOXO1—obesity	9.85e-05	0.0001	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—RPS6KB1—obesity	9.83e-05	0.0001	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—APOA1—obesity	9.83e-05	0.0001	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—LPL—obesity	9.82e-05	0.0001	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—PIK3CB—obesity	9.77e-05	9.95e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—FOXO1—obesity	9.75e-05	9.94e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—RPS6KB1—obesity	9.74e-05	9.92e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—PIK3CB—obesity	9.74e-05	9.92e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—PIK3CB—obesity	9.64e-05	9.82e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PRKCD—obesity	9.17e-05	9.34e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PRKCD—obesity	9.14e-05	9.31e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PRKCD—obesity	9.05e-05	9.22e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PIK3CG—obesity	8.98e-05	9.15e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—HTR2A—obesity	8.97e-05	9.14e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—C3—obesity	8.96e-05	9.13e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—HTR2A—obesity	8.95e-05	9.11e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—C3—obesity	8.93e-05	9.1e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—HTR2A—obesity	8.86e-05	9.03e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—C3—obesity	8.85e-05	9.01e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PPARG—obesity	8.66e-05	8.83e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—POMC—obesity	8.54e-05	8.71e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—IRS2—obesity	8.53e-05	8.69e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—AGT—obesity	8.51e-05	8.68e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—IRS2—obesity	8.5e-05	8.66e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—INS—obesity	8.5e-05	8.66e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—AGT—obesity	8.49e-05	8.65e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—IRS2—obesity	8.42e-05	8.57e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—AGT—obesity	8.41e-05	8.56e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—APOE—obesity	8.34e-05	8.5e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—LEP—obesity	8.34e-05	8.5e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—LEP—obesity	8.32e-05	8.47e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—APOE—obesity	8.32e-05	8.47e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CAV1—obesity	8.27e-05	8.42e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—APOA1—obesity	8.25e-05	8.4e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CAV1—obesity	8.24e-05	8.4e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—APOE—obesity	8.24e-05	8.39e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—LEP—obesity	8.24e-05	8.39e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—APOA1—obesity	8.22e-05	8.38e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CAV1—obesity	8.16e-05	8.31e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—APOA1—obesity	8.14e-05	8.3e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—ESR1—obesity	7.96e-05	8.12e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—ESR1—obesity	7.94e-05	8.09e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PIK3CD—obesity	7.89e-05	8.04e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—F2—obesity	7.87e-05	8.02e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PRKCB—obesity	7.87e-05	8.02e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—ESR1—obesity	7.86e-05	8.01e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—F2—obesity	7.84e-05	7.99e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PRKCB—obesity	7.84e-05	7.99e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—ALB—obesity	7.79e-05	7.94e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—BAD—obesity	7.77e-05	7.92e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PRKCB—obesity	7.77e-05	7.91e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—F2—obesity	7.77e-05	7.91e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—BAD—obesity	7.75e-05	7.9e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—BAD—obesity	7.67e-05	7.82e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PIK3CG—obesity	7.53e-05	7.67e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PIK3CG—obesity	7.51e-05	7.65e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PIK3R1—obesity	7.45e-05	7.59e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—NOS3—obesity	7.45e-05	7.59e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—IRS1—obesity	7.44e-05	7.58e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PIK3CG—obesity	7.43e-05	7.57e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—IRS1—obesity	7.42e-05	7.56e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—IRS1—obesity	7.35e-05	7.49e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—POMC—obesity	7.17e-05	7.3e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—POMC—obesity	7.14e-05	7.28e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—INS—obesity	7.13e-05	7.26e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—INS—obesity	7.1e-05	7.24e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—POMC—obesity	7.07e-05	7.21e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—INS—obesity	7.04e-05	7.17e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CCL2—obesity	7.01e-05	7.15e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CCL2—obesity	6.99e-05	7.12e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CCL2—obesity	6.92e-05	7.05e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—IGF1—obesity	6.89e-05	7.02e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—AKT2—obesity	6.89e-05	7.02e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PIK3CB—obesity	6.88e-05	7.01e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—IGF1—obesity	6.87e-05	7e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—AKT2—obesity	6.87e-05	7e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PTGS2—obesity	6.81e-05	6.94e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—IGF1—obesity	6.81e-05	6.93e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—AKT2—obesity	6.8e-05	6.93e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PIK3CD—obesity	6.62e-05	6.74e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PIK3CD—obesity	6.6e-05	6.72e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—PIK3CA—obesity	6.56e-05	6.68e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—SERPINE1—obesity	6.55e-05	6.67e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—PIK3CA—obesity	6.54e-05	6.66e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PIK3CD—obesity	6.53e-05	6.66e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—SERPINE1—obesity	6.53e-05	6.65e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—PIK3CA—obesity	6.47e-05	6.59e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—SERPINE1—obesity	6.46e-05	6.58e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—TYK2—obesity	6.37e-05	6.49e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—TYK2—obesity	6.35e-05	6.47e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—RHOA—obesity	6.32e-05	6.43e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—RHOA—obesity	6.3e-05	6.41e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—TYK2—obesity	6.29e-05	6.4e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—NOS3—obesity	6.25e-05	6.37e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PIK3R1—obesity	6.25e-05	6.37e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—RHOA—obesity	6.23e-05	6.35e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—NOS3—obesity	6.23e-05	6.35e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PIK3R1—obesity	6.23e-05	6.35e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PIK3R1—obesity	6.17e-05	6.29e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—NOS3—obesity	6.17e-05	6.29e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—PIK3CA—obesity	5.95e-05	6.07e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—PIK3CA—obesity	5.93e-05	6.05e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—PIK3CA—obesity	5.88e-05	5.99e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PIK3CB—obesity	5.77e-05	5.88e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—MTOR—obesity	5.77e-05	5.88e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—MTOR—obesity	5.75e-05	5.86e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PIK3CB—obesity	5.75e-05	5.86e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—MTOR—obesity	5.7e-05	5.8e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PIK3CB—obesity	5.7e-05	5.8e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—AKT1—obesity	5.36e-05	5.46e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—AKT1—obesity	5.34e-05	5.44e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—AKT1—obesity	5.29e-05	5.39e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—IL6—obesity	5.27e-05	5.37e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—IL6—obesity	5.26e-05	5.35e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—IL6—obesity	5.2e-05	5.3e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—MMP9—obesity	5.01e-05	5.11e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—MMP9—obesity	5e-05	5.09e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—MMP9—obesity	4.95e-05	5.04e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—MAPK8—obesity	4.88e-05	4.97e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—AKT1—obesity	4.86e-05	4.96e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—MAPK8—obesity	4.86e-05	4.95e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—AKT1—obesity	4.85e-05	4.94e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—MAPK8—obesity	4.81e-05	4.91e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—AKT1—obesity	4.8e-05	4.89e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—STAT3—obesity	4.46e-05	4.54e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—STAT3—obesity	4.44e-05	4.53e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—STAT3—obesity	4.4e-05	4.48e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PIK3CA—obesity	4.19e-05	4.27e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—MYC—obesity	4.14e-05	4.22e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—TGFB1—obesity	4.13e-05	4.21e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—MYC—obesity	4.13e-05	4.21e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—TGFB1—obesity	4.12e-05	4.2e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—MYC—obesity	4.09e-05	4.17e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—TGFB1—obesity	4.08e-05	4.16e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PIK3CA—obesity	3.52e-05	3.58e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PIK3CA—obesity	3.51e-05	3.57e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PIK3CA—obesity	3.47e-05	3.54e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—AKT1—obesity	3.43e-05	3.49e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—IL6—obesity	3.11e-05	3.17e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—IL6—obesity	3.1e-05	3.16e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—IL6—obesity	3.07e-05	3.13e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—AKT1—obesity	2.87e-05	2.93e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—AKT1—obesity	2.86e-05	2.92e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—AKT1—obesity	2.84e-05	2.89e-05	CbGpPWpGaD
